Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Oncology Letters
      • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Biomedical Reports
      • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • Information for Authors
    • Information for Reviewers
    • Information for Librarians
    • Information for Advertisers
    • Conferences
  • Language Editing
Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • For Authors
    • For Reviewers
    • For Librarians
    • For Advertisers
    • Conferences
  • Language Editing
Login Register Submit
  • This site uses cookies
  • You can change your cookie settings at any time by following the instructions in our Cookie Policy. To find out more, you may read our Privacy Policy.

    I agree
Search articles by DOI, keyword, author or affiliation
Search
Advanced Search
presentation
Molecular Medicine Reports
Join Editorial Board Propose a Special Issue
Print ISSN: 1791-2997 Online ISSN: 1791-3004
Journal Cover
January-2018 Volume 17 Issue 1

Full Size Image

Sign up for eToc alerts
Recommend to Library

Journals

International Journal of Molecular Medicine

International Journal of Molecular Medicine

International Journal of Molecular Medicine is an international journal devoted to molecular mechanisms of human disease.

International Journal of Oncology

International Journal of Oncology

International Journal of Oncology is an international journal devoted to oncology research and cancer treatment.

Molecular Medicine Reports

Molecular Medicine Reports

Covers molecular medicine topics such as pharmacology, pathology, genetics, neuroscience, infectious diseases, molecular cardiology, and molecular surgery.

Oncology Reports

Oncology Reports

Oncology Reports is an international journal devoted to fundamental and applied research in Oncology.

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine is an international journal devoted to laboratory and clinical medicine.

Oncology Letters

Oncology Letters

Oncology Letters is an international journal devoted to Experimental and Clinical Oncology.

Biomedical Reports

Biomedical Reports

Explores a wide range of biological and medical fields, including pharmacology, genetics, microbiology, neuroscience, and molecular cardiology.

Molecular and Clinical Oncology

Molecular and Clinical Oncology

International journal addressing all aspects of oncology research, from tumorigenesis and oncogenes to chemotherapy and metastasis.

World Academy of Sciences Journal

World Academy of Sciences Journal

Multidisciplinary open-access journal spanning biochemistry, genetics, neuroscience, environmental health, and synthetic biology.

International Journal of Functional Nutrition

International Journal of Functional Nutrition

Open-access journal combining biochemistry, pharmacology, immunology, and genetics to advance health through functional nutrition.

International Journal of Epigenetics

International Journal of Epigenetics

Publishes open-access research on using epigenetics to advance understanding and treatment of human disease.

Medicine International

Medicine International

An International Open Access Journal Devoted to General Medicine.

Journal Cover
January-2018 Volume 17 Issue 1

Full Size Image

Sign up for eToc alerts
Recommend to Library

  • Article
  • Citations
    • Cite This Article
    • Download Citation
    • Create Citation Alert
    • Remove Citation Alert
    • Cited By
  • Similar Articles
    • Related Articles (in Spandidos Publications)
    • Similar Articles (Google Scholar)
    • Similar Articles (PubMed)
  • Download PDF
  • Download XML
  • View XML
Article Open Access

Trichosanthes kirilowii extract enhances repair of UVB radiation‑induced DNA damage by regulating BMAL1 and miR‑142‑3p in human keratinocytes

  • Authors:
    • Ji‑Hye Joo
    • In‑Kee Hong
    • Nam Kyoung Kim
    • Eunmi Choi
  • View Affiliations / Copyright

    Affiliations: Research and Development Center, Greensolutions Co., Ltd., Chuncheon, Gangwon 24232, Republic of Korea, Research and Development Center, Radiant Co., Ltd., Chuncheon, Gangwon 24398, Republic of Korea
    Copyright: © Joo et al. This is an open access article distributed under the terms of Creative Commons Attribution License.
  • Pages: 877-883
    |
    Published online on: October 31, 2017
       https://doi.org/10.3892/mmr.2017.7932
  • Expand metrics +
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )
Cited By (CrossRef): 0 citations Loading Articles...

This article is mentioned in:



Abstract

Ultraviolet B (UVB) radiation induces DNA damage, oxidative stress and inflammation, and suppresses the immune system in the skin, which collectively contribute to skin aging and carcinogenesis. The DNA damage response, including DNA repair, can be regulated by the circadian clock and microRNA (miRNA) expression. The aim of the present study was to evaluate the reparative action of Trichosanthes kirilowii extract (TKE) against UVB irradiation‑induced DNA damage in human keratinocytes. TKE demonstrated low cytotoxicity in normal HaCaT keratinocytes at low doses (up to 100 µg/ml). The results of a comet assay revealed that TKE enhanced the repair of UVB‑induced DNA damage. TKE significantly upregulated the expression of the core clock protein, brain and muscle aryl hydrocarbon receptor nuclear translocator‑like protein‑1 (BMAL1), and downregulated the expression of miRNA (miR)‑142‑3p, as demonstrated using western blotting and the reverse transcription‑quantitative polymerase chain reaction. Furthermore, the suppression of miR‑142‑3p by a specific inhibitor positively correlated with the repair activity. Overall, the data obtained demonstrated that TKE enhanced the repair of UVB‑induced DNA damage by regulating the expression of BMAL1 and miR‑142‑3p. Consequently, TKE can be considered a potential candidate for the treatment of skin diseases associated with UVB‑induced damage.

Introduction

Ultraviolet (UV) radiation leads to DNA damage, cell senescence and apoptosis. It also results in the formation of the two most common DNA lesions, cyclobutane pyrimidine dimers and 6–4 photoproducts. These lesions impede DNA replication and transcription, and are repaired by nucleotide excision repair (NER) (1,2). NER is critical in the repair of UV-induced DNA lesions and its actions involve the endonucleolytic cleavage of two phosphodiester bonds followed by excision of the damaged DNA. The excised oligonucleotide is replaced by DNA repair synthesis, and the continuity of the DNA strand is re-established by DNA ligase (3).

The circadian rhythm is responsible for regulating various physiological processes, including hormone production, temperature and sleep pattern. It is found in the majority of living organisms, including animals, plants and fungi. The mammalian circadian clock system is organized as a central oscillator. This system is controlled by the suprachiasmatic nucleus (SCN) and the peripheral oscillators (4–6). The core clock oscillator includes the two heterodimeric transcriptional factors, CLOCK and brain and muscle aryl hydrocarbon receptor nuclear translocator (ARNT)-like protein-1 (BMAL1), which activates the transcription of their transcriptional repressors, Period (Per) and Cryptochrome (Cry) (5,6).

The DNA damage response pathways include DNA repair, damage checkpoints and cell cycle arrest. Current evidence indicates that these pathways are associated with the circadian clock (2,7,8). Furthermore, there is evidence that the normal circadian rhythm and gene expression levels in the skin are suppressed by UVB radiation, as has been demonstrated for the gene expression levels of Bmal1, Per and Clock in human keratinocytes (9,10).

MicroRNAs (miRNAs) are small non-coding RNA molecules, which are involved in the regulation of gene expression by binding to the 3′-untranslated regions (UTRs) of target mRNAs and thus interrupting protein translation (11–13). Numerous studies have shown that miRNAs are important in biological processes, including cell proliferation, apoptosis, development, metabolism and differentiation (14–17). Previous studies have implicated miRNAs in the modulation of the circadian clock, revealing that miRNA (miR)-219 regulates the length of the circadian period, whereas miR-132 modulates Per gene transcription and protein stability (18,19). Although miR-142-3p is present in other cells, it is involved in the post-translational modulation of BMAL1 in mouse SCN, NIH3T3 and human 293ET cells (20,21); however, the molecular mechanisms by which miR-142-3p mediates the post-transcriptional regulation of BMAL1 in skin cells remain to be elucidated. Several studies have reported an association between UV radiation exposure and alterations in miRNA expression in keratinocytes (22,23). UVB radiation-exposed keratinocytes exhibit several specific miRNA response patterns (24).

Trichosanthes kirilowii is a traditional medicine used in East Asia for treating patients with diabetes, cancer-associated symptoms, coughing and breast abscesses (25,26). However, the effects of T. kirilowii on skin cells and its effect on DNA damage repair remain to be fully elucidated. Therefore, the aim of the present study was to investigate the effects of T. kirilowii extract (TKE) against UVB-induced DNA damage in skin cells. In addition, the involvement of miR-142-3p and BMAL1 in the TKE-mediated repair of UVB-induced DNA damage was investigated.

Materials and methods

Preparation of TKE

The T. kirilowii plant material used in the present study was purchased from Jeong-woo-dang Oriental Medicine Market (Seoul, Korea). To prepare the TKE, the powdered T. kirilowii (50 g) was extracted for 3 h with 70% ethanol (1 liter) at room temperature (20–25°C) while stirring. The supernatant was collected by filtration, and the ethanol was removed using a rotary vacuum evaporator.

Cell culture conditions

The HaCaT cells were obtained from Cell Line Service GmbH (Eppelheim, Germany) and were cultured in Dulbecco's modified Eagle's medium (DMEM) containing 10% fetal bovine serum (FBS) and 1% penicillin/streptomycin (all HyClone; GE Healthcare Life Sciences, Logan, UT, USA) in a humidified atmosphere of 5% CO2 at 37°C.

UVB exposure and subsequent TKE treatment

The HaCaT cells were incubated in serum-free medium for 24 h in culture plates, washed twice in phosphate-buffered saline (PBS), exposed to the desired doses (12.5 mJ/cm2) of UVB radiation under a thin layer of PBS, and then immediately incubated with serum-free medium containing various concentrations of TKE (25, 50, 100 and 200 µg/ml) for 24 h in in a humidified atmosphere of 5% CO2 at 37°C.

Measurement of cell viability using a 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay

The HaCaT cells were cultured in 96-well plates (1×104 cells/well) for 24 h in complete and serum-free media, sequentially. The cells were exposed to UVB radiation and then incubated with serum-free medium containing various concentrations (25–200 µg/ml) of TKE. Following culture for 24 h, the cell viability was determined using the MTT assay. Briefly, to each well, 20 µl of MTT solution (5 mg/ml) was added and the plate was incubated for an additional 4 h at 37°C. The formazan product, which formed was solubilized in 100 µl of isopropanol, and the absorbance was measured at 560 nm.

Western blot analysis

The cells were rinsed twice with ice-cold PBS, following which cell lysates were prepared using radioimmunoprecipitation assay lysis buffer, comprising 150 mM sodium chloride, 1% Triton X-100, 0.5% sodium deoxycholate, 0.1% sodium dodecyl sulfate (SDS), and 50 mM Tris-hydrochloride (pH 8.0) containing a protease inhibitor cocktail. The lysate protein concentrations were determined using bicinchoninic acid reagent. The cell lysate samples (40 µg) were then separated using 8% SDS-polyacrylamide gel electrophoresis and blotted onto polyvinylidene difluoride membranes. The membranes were blocked with 5% bovine serum albumin (Sigma-Aldrich; Merck KGaA) in 1X TBS Tween-20 buffer for 20 min at room temperature. The membranes were incubated with anti-human BMAL1 (1:3,000; cat. no. SC-8550; Abcam, Cambridge, MA, USA) or anti-human actin (1:1,000; cat. no. SC-1615-R; Santa Cruz Biotechnology, Inc., Dallas, TX, USA) at 4°C overnight, followed by incubation with a horseradish peroxidase-conjugated secondary antibody (1:10,000; cat. no. SC-2768; Santa Cruz Biotechnology, Inc.) at room temperature for 1 h. Finally, the protein-antibody conjugates on the membranes were visualized using enhanced chemiluminescence reagents (Thermo Fisher Scientific, Inc., Waltham, MA, USA).

Comet assay (single-cell gel electrophoresis)

Following UVB radiation, the cells were scraped and embedded in low melting point agarose on CometSlides™ (Trevigen, Gaithersburg, MD, USA) at 4°C for 10 min. The slides were then incubated with lysis buffer at 4°C for 1 h, followed by immersion in an alkaline unwinding solution for 30 min at room temperature (20–25°C). The slides were electrophoresed at 50 V, rinsed with distilled water and 70% ethanol, and then stained with SYBR®−Green (Trevigen) for 10 min. The DNA damage was visualized using a fluorescent microscope (IX71; Olympus Corporation, Tokyo Japan). These data were analyzed with analySIS LS Starter version 2.2 (Olympus Soft Imaging Solutions GmbH, Münster, Germany).

Reverse transcription-polymerase chain reaction (RT-PCR) analysis

Total RNA was extracted from the cells using TRIzol reagent (Invitrogen; Thermo Fisher Scientific, Inc.) according to the manufacturer's protocol. The RNA concentration was quantified using a UV spectrophotometer, and cDNA was synthesized from 1 µg total RNA. The cDNA (250 ng) was then subjected to a PCR using EmeraldAmp® GT PCR master mix (Takara Bio, Inc., Otsu, Japan). The primers (10 pmol) used for PCR analysis were synthesized by Bioneer Corporation (Daejeon, Korea). The cycling conditions were as follows: 30 cycles at 94°C for 30 sec, 60°C for 1 min, and 72°C for 30 sec. The primer sequences used were as follows: BMAL1, forward 5′-AAGGATGGCTGTTCAGCACA-3′ and reverse 5′-CAAAAATCCATGGCTGCCC-3′; and β-actin, forward 5′-ACACTGTGCCCATCTACG-GGGG-3′ and reverse 5′-ATGATGGAGTTGAAGGTAGTTTCGTGGAT-3′. The PCR products were run on 2% agarose gels containing ethidium bromide.

Bioinformatic analysis

The target gene prediction database Targetscan (version 6.2; targetscan.org) was used to search for predicted BMAL-1-targeted miRNAs.

RT-quantitative PCR (RT-qPCR) analysis

The RNA (1 µg) was reverse-transcribed using the Mir-X™ miRNA First-Strand Synthesis kit (Clontech Laboratories, Inc., Mountain View, CA, USA) to generate cDNA. The LightCycler® 480 SYBR-Green I Master (Roche Diagnostics, Inc., Indianapolis, IN, USA) was used for the RT-qPCR procedure, according to the manufacturer's protocol to quantify the miRNA transcript levels. The appropriate quantification cycle (Cq) value was determined using the automatic baseline determination feature. The reaction solution contained 10 µl 2X Master Mix, 1 µl miR-specific primer for human miR-142-3p, 1 µl universal primer, cDNA (100 ng) and nuclease-free water to a total volume of 20 µl. The sequence of the hsa-miR-142-3p primer was as follows: 5′-TGTAGTTTCCTACTTTATGGA-3′. U6 was used for miRNA level normalization. The U6 primer was as follows: Forward, 5′-CCUCGUGCCGUUCCAGGUAGUU-3′ and reverse, 5′-CUACCUGAUGAACGGCAGGUU-3′. DNA was amplified using 45 cycles of denaturation for 10 sec at 95°C and annealing for 10 sec at 60°C. Each sample was assessed in triplicate. The relative expression of the miRNA was quantified using Lightcycler® 480 II software (Roche Diagnostics Inc., Indianapolis, IN, USA) and the 2−ΔΔCq method (27).

Transient transfection with synthetic miRNA mimics and inhibitors

The mimic and inhibitor oligonucleotides for miR-142-3p and the negative controls were synthesized by Genolution Pharmaceutical (Seoul, Korea). Prior to miRNA transfection, the HaCaT cell culture medium was replaced with serum-reduced medium of opti-minimal essential medium (MEM) I (Gibco; Thermo Fisher Scientific, Inc.). The transfection was performed using Lipofectamine 2000 (Invitrogen; Thermo Fisher Scientific, Inc.) according to the manufacturer's protocol. The HaCaT cells were incubated with the oligonucleotides/lipofectamine mixture for 6 h, following which the opti-MEM I medium was replaced with the growth medium. The cells were harvested 24 h following transfection.

Statistical analysis

Statistical analysis was performed using Student's t-test and was based on at least three independent experiments. P<0.05 was considered to indicate a statistically significant difference. The GraphPad Prism 5 program (GraphPad Software, Inc., La Jolla, CA, USA) was used to evaluate statistical significance.

Results

TKE promotes the repair of UVB-mediated DNA damage in HaCaT cells

DNA damage is caused by UV radiation. Keratinocytes are affected by UV radiation in the outermost layer of skin. HaCaT cells are a spontaneously immortal keratinocyte cell line, which has been widely used in investigations involving the skin. The present study first examined the effect of TKE at concentrations of 25, 50, 100 and 200 µg/ml on the viability of HaCaT cells treated for 24 h using an MTT assay. As shown in Fig. 1A, TKE at a concentration of 200 µg/ml, but not at concentrations of ≤100 µg/ml, was significantly cytotoxic and, based on these results; concentrations of 50–100 µg/ml were selected for use in the subsequent experiments.

Figure 1.

Effects of TKE on DNA repair in UVB radiation-exposed HaCaT cells. (A) Cell viability of TKE-treated cells was measured using a 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide assay. Results are presented as the mean ± standard deviation of three independent experiments. (B) HaCaT cells were exposed to UVB radiation (12.5 mJ/cm2) with or without TKE treatment (50 and 100 µg/ml). UVB-induced DNA damage was determined using a comet assay. Comet tails were measured in each cell under a microscope and expressed as the mean ± standard deviation (µm) of at least 30 cells in each treatment group. *P<0.05, compared with the UVB-exposed control. TKE, ethanol extract of Trichosanthes kirilowii; UVB, ultraviolet B.

The reparative and protective effects of 8 h treatment with TKE against DNA damage induced by UVB radiation were determined in HaCaT cells using a comet assay. The exposure of HaCaT cells to UVB radiation (12.5 mJ/cm2) induced extensive DNA damage, as reflected in the difference in tail lengths between the comets of the cells exposed to UVB radiation and those not exposed (Fig. 1B). However, treatment of the UVB-exposed cells with TKE (100 µg/ml) reduced the DNA damage or fragmentation, compared with that in the untreated UVB-exposed cells (Fig. 1B). In addition, the preliminary experiments indicated that TKE protected the HaCaT cells from UVB-induced DNA damage (data not shown). These findings demonstrated that TKE may be involved in DNA damage repair and may also protect against UVB-induced DNA damage.

TKE modulates mRNA and protein expression levels of BMAL1 in UVB-irradiated HaCaT cells

The results of the present study demonstrated that TKE exhibited reparative effects on UVB-induced DNA damage (Fig. 1B). Several reports have indicated that the NER DNA repair system is dependent on the circadian rhythm (28–30). To further investigate the molecular mechanism by which TKE modulates DNA damage repair, the present study examined changes in the expression of BMAL1, which is important in the circadian rhythm (9,10). The UVB radiation decreased the mRNA and protein expression levels of BMAL1, compared with levels in the unstimulated control cells, which was consistent with a previous report using normal human keratinocytes (10). However, TKE (100 µg/ml) treatment markedly increased mRNA and protein the expression of BMAL1 (Fig. 2A and B). Overall, TKE treatment affected the expression levels of BMAL1, suggesting that specific cellular response mechanisms may be involved in TKE-mediated DNA damage repair in keratinocytes.

Figure 2.

Effects of TKE on mRNA and protein expression of BMAL1. Levels of BMAL1 in HaCaT cells were determined using (A) reverse transcription-polymerase chain reaction and (B) western blot analysis. β-actin and actin were used as internal controls. Results were obtained from at least three independent experiments. Data were analyzed using analySIS LS Starter. TKE, ethanol extract of Trichosanthes kirilowii; BMAL1, brain and muscle aryl hydrocarbon receptor nuclear translocator-like protein-1.

TKE upregulates the expression of BMAL1 via the inhibition of miR-142-3p

It has been reported that miRNAs are closely associated with the regulation of DNA damage in addition to circadian rhythms (31). To determine the potential regulatory role of BMAL1-targeted specific miRNAs in target gene transcription, the present study used TargetScan to predict BMAL1-targeted specific miRNAs in the HaCaT cells. It was found that miR-142-3p showed a high level of interaction with the 3′-UTR of BMAL1 and a high probability of regulating the expression of BMAL1. A previous study demonstrated that miR-142-3p directly targeted BMAL1 3′-UTRs and regulated the mRNA and protein levels of BMAL1 in human 293ET cells (21). To investigate whether miR-142-3p is involved in the regulation of BMAL1 in human keratinocytes, the HaCaT cells were transfected for 24 h with the miR-142-3p mimic and a mimic control. The results of the subsequent RT-qPCR analysis demonstrated that the miR-142-3p mimic significantly increased the expression of miR-142-3p in the HaCaT cells, compared with that in cells transfected with the mimic control (Fig. 3A). Furthermore, the results of western blot analysis demonstrated that the miR-142-3p mimic markedly inhibited the protein expression of BMAL1 (Fig. 3B). The results of the RT-PCR analysis also revealed that the mimic suppressed the mRNA expression levels of BMAL1 (data not shown). Taken together, the downregulation of the mRNA and protein expression of BMAL1 in HaCaT cells suggested that miR-142-3p may be involved in the molecular mechanisms underlying the repair of and protection against UVB-induced DNA damage.

Figure 3.

Effects of TKE on expression of BMAL1 are mediated by the downregulation of miR-142-3p. (A) Cultured HaCaT cells were transfected with 20, 50 and 100 nM miR-142-3p mimic or miR-142-3p mimic NC. The expression of miR-142-3p was examined using RT-qPCR analysis. **P<0.01, compared with NC. (B) Western blot analysis was used to measure the expression of BMAL1 in transfected HaCaT cells. (C) HaCaT cells were exposed to UVB radiation with or without TKE treatment. Expression levels of miR-142-3p were determined using RT-qPCR; *P<0.05, compared with UVB-exposed control. TKE, ethanol extract of Trichosanthes kirilowii; BMAL1, brain and muscle aryl hydrocarbon receptor nuclear translocator-like protein-1; miR, microRNA; UVB, ultraviolet B; RT-qPCR, reverse transcription-quantitative polymerase chain reaction; NC, negative control.

Based on the above findings, the present study examined the effects of TKE on miRNA expression levels in the HaCaT cells. To investigate whether the expression of BMAL1 is regulated by TKE through the modulation of miR-142-3p, RT-qPCR analysis was performed in the HaCaT cells treated with or without TKE. In the HaCaT cells exposed to UVB radiation (12.5 mJ/cm2) for 24 h, the expression levels of miR-142-3p were increased, however, in UVB-exposed cells treated with TKE (100 µg/ml) for 24 h, a decrease in the expression of miR-142-3p was observed (Fig. 3C). Taken together, these observations suggested that TKE-mediated DNA damage repair in HaCaT cells may be correlated with suppression of the expression of miR-142-3p.

miR-142-3p suppresses the repair of UVB-induced DNA damage

To examine the role of miRNAs in the repair of UVB-induced DNA damage, a comet assay was performed in the HaCaT cells. The cells were transfected with the miR-142-3p mimic, mimic control, miR-142-3p inhibitor, or inhibitor control. As shown in Fig. 4A and B, the miR-142-3p mimic-transfected cells exhibited increased DNA damage, compared with the cells not exposed to UVB. However, the mimic negative control showed no observable effects in the cells.

Figure 4.

Effects of miR-142-3p on UVB-induced DNA damage in HaCaT cells. UVB-induced DNA damage was determined using a comet assay. (A) Representative immunofluorescence images and (B) graph of the results. The comet tails of each cell were measured using a microscope and expressed as the mean ± standard deviation of at least 30 cells in each treatment group. *P<0.05, compared with non-UVB-exposed control. Cultured HaCaT cells were pre-treated with miR-142-3p inhibitor and miR-142-3p inhibitor NC and then exposed to UVB radiation. Cells were harvested 8 h after exposure. (C) Representative immunofluorescence images and (D) graph of the results. Comet tails of each cell were measured using a microscope and expressed as the mean ± standard deviation of at least 30 cells in each treatment group. *P<0.05 and **P<0.01, compared with the UVB-exposed control. These data were analyzed with analySIS LS Starter. TKE, ethanol extract of Trichosanthes kirilowii; BMAL1, brain and muscle aryl hydrocarbon receptor nuclear translocator-like protein-1; miR, microRNA; UVB, ultraviolet B; NC, negative control.

The present study then determined whether the miR-142-3p inhibitor affected the repair of UVB-induced DNA damage in HaCaT cells and found that it significantly decreased the expression of miR-142-3p in HaCaT cells, compared with control cells transfected with the inhibitor control (data not shown). The miR-142-3p inhibitor-transfected cells exhibited reduced DNA damage, compared with the UVB-exposed cells (Fig. 4C and D). These results indicated that miR-142-3p inhibited the repair of UVB-induced DNA damage in HaCaT cells. Taken together, these results suggested that TKE enhanced the repair of UVB-induced DNA damage by regulating the expression of miR-142-3p and BMAL1.

Discussion

T. kirilowii has been used in the treatment of diabetes, respiratory diseases, and cancer-related symptoms (25,26). The extracts and active components of T. kirilowii have been reported to exert anticancer activities (32). However, the effects of T. kirilowii on skin cells and its effect on DNA damage repair have not been reported previously. In the present study, the reparative effect of TKE was shown on UVB-induced DNA damage in HaCaT keratinocytes, which was likely mediated by regulation of the circadian clock and miRNA expression.

DNA damage is caused by UV radiation. The DNA damage response includes the DNA repair system, NER. The mechanism underlying NER has been shown to involve the circadian rhythm. Several reports have indicated that the circadian oscillations of NER activity are associated with that of the protein level of xeroderma pigmentosum group A (XPA) (2,7,8,28). XPA is crucial in DNA damage recognition and has a regulatory function on the circadian clock. XPA is positively regulated by CLOCK and BMAL1, and negatively regulated by CRY and PER (29). BMAL1 is closely associated with time-dependent UV sensitivity and the efficiency of DNA repair (30). These findings are consistent with a previous report that BMAL1-silenced cells showed markedly reduced DNA repair responses (33) and another study, which reported that BMAL1 regulates the proportion of cells in the S-phase of the cell cycle, which are sensitive to DNA damage (30). In the present study, DNA damage was measured in human keratinocytes (HaCaT cells) using a comet assay. The comet tail lengths of cells treated with UVB followed by 100 µg/ml TKE showed a significant decrease compared to that of the UVB-treated controls. TKE exerted reparative effects against UVB-induced DNA damage (Fig. 1A). In addition, TKE upregulated the UVB-reduced expression of BMAL1 (Fig. 2). Therefore, these results suggested that TKE regulated the expression of BMAL1, which repaired keratinocytes and protected them from UVB-induced damage. These events appear to be associated with the BMAL1-modulated DNA repair system.

The NER system is regulated by miRNA-mediated gene regulation. Several miRNAs have been implicated in the DNA repair pathway. The upregulation of miR-192, miR-890 and miR-744-2p inhibits NER in cancer cells (31). In the present study, the expression levels of miR-142-3p were significantly decreased in the TKE-treated HaCaT cells exposed to UVB, compared with the unexposed cells (Fig. 3C). Several previous studies have reported that miR-142-3p is expressed in the spleen, thymus and hematopoietic cells (33–35). It has also been reported that miR-142-3p functions as a tumor suppressor by targeting numerous tumor-associated genes (36,37). miR-142-3p has been shown to be expressed at significantly higher levels in cells from patients with psoriasis and atopic dermatitis, compared with normal cells (38,39). In addition, miR-142-3p was found to be upregulated in patients with systemic sclerosis (40). From these previous findings, it was hypothesized that miR-142-3p may be involved in other skin diseases.

Previous studies have demonstrated that miRNAs are important regulators of the circadian clock. miR-142-3p directly targets BMAL1 3′-UTRs and regulates the mRNA and protein levels of BMAL1 in mouse SCN, NIH3T3 and human 293ET cells (20,21). In the present study, the miR-142-3p mimic markedly inhibited the protein expression of BMAL1 in human keratinocytes (Fig. 3B). The miR-142-3p mimic increased comet tail length, compared with that of control cells without UVB exposure (Fig. 4A and B). The miR-142-3p inhibitor suppressed the repair of UVB-induced DNA damage in the HaCaT cells by its regulation of potential target genes, including bmal1 (Fig. 4C and D). These findings provide a novel basis for the correlation between the regulation of BMAL1 and the suppression of miR-142-3p by TKE.

Although the present study focused on the repair mechanism of DNA damage by BMAL1 and miR-142-3p, this may constitute only one of numerous mechanisms, which may include regulation by other clock factors within the circadian clock gene or other miRNAs. Further investigations are necessary to identify the active component in TKE and to determine the detailed mechanism involved in the BMAL1-mediated repair of UVB-induced DNA damage. In conclusion, the results of the present study provided evidence of the beneficial effects of TKE in the repair of UVB-induced DNA damage in HaCaT cells. These findings may have important implications for the treatment of various diseases caused by UVB-induced photodamage, including photoaging and sunburn.

Glossary

Abbreviations

Abbreviations:

TKE

Trichosanthes kirilowii extract

BMAL1

brain and muscle aryl hydrocarbon receptor nuclear translocator-like protein-1

UVB

ultraviolet B radiation

Per

period

Cry

cryptochrome

miR-142-3p

microRNA 142-3p

References

1 

Sinha RP and Häder DP: UV-induced DNA damage and repair: A review. Photochem Photobiol Sci. 1:225–236. 2002. View Article : Google Scholar : PubMed/NCBI

2 

Sancar A, Lindsey-Boltz LA, Kang TH, Reardon JT, Lee JH and Ozturk N: Circadian clock control of the cellular response to DNA damage. FEBS Lett. 584:2618–2625. 2010. View Article : Google Scholar : PubMed/NCBI

3 

Sancar A: DNA excision repair. Annu Rev Biochem. 65:43–81. 1996. View Article : Google Scholar : PubMed/NCBI

4 

Matsunaga N, Itcho K, Hamamura K, Ikeda E, Ikeyama H, Furuichi Y, Watanabe M, Koyanagi S and Ohdo S: 24-Hour rhythm of aquaporin-3 function in the epidermis is regulated by molecular clocks. J Invest Dermatol. 134:1636–1644. 2014. View Article : Google Scholar : PubMed/NCBI

5 

Watanabe M, Hida A, Kitamura S, Enomoto M, Ohsawa Y, Katayose Y, Nozaki K, Moriguchi Y, Aritake S, Higuchi S, et al: Rhythmic expression of circadian clock genes in human leukocytes and beard hair follicle cells. Biochem Biophys Res Commun. 425:902–907. 2012. View Article : Google Scholar : PubMed/NCBI

6 

Ando N, Nakamura Y, Aoki R, Ishimaru K, Ogawa H, Okumura K, Shibata S, Shimada S and Nakao A: Circadian gene clock regulates psoriasis-like skin inflammation in mice. J Invest Dermatol. 135:3001–3008. 2015. View Article : Google Scholar : PubMed/NCBI

7 

Desotelle JA, Wilking MJ and Ahmad N: The circadian control of skin and cutaneous photodamage. Photochem Photobiol. 88:1037–1047. 2012. View Article : Google Scholar : PubMed/NCBI

8 

Kang T and Sancar A: Circadian regulation of DNA excision repair: Implications for chrono-chemotherapy. Cell Cycle. 8:1665–1667. 2009. View Article : Google Scholar : PubMed/NCBI

9 

Gery S, Komatsu N, Baldjyan L, Yu A, Koo D and Koeffler HP: The circadian gene per1 plays an important role in cell growth and DNA damage control in human cancer cells. Mol Cell. 22:375–382. 2006. View Article : Google Scholar : PubMed/NCBI

10 

Kawara S, Mydlarski R, Mamelak AJ, Freed I, Wang B, Watanabe H, Shivji G, Tavadia SK, Suzuki H, Bjarnason GA, et al: Low-dose ultraviolet B rays alter the mRNA expression of the circadian clock genes in cultured human keratinocytes. J Invest Dermatol. 119:1220–1223. 2002. View Article : Google Scholar : PubMed/NCBI

11 

Bartel DP: MicroRNAs: Genomics, biogenesis, mechanism, and function. Cell. 116:281–297. 2004. View Article : Google Scholar : PubMed/NCBI

12 

Lewis BP, Burge CB and Bartel DP: Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets. Cell. 120:15–20. 2005. View Article : Google Scholar : PubMed/NCBI

13 

Ambros V and Lee RC: Identification of microRNAs and other tiny noncoding RNAs by cDNA cloning. Methods Mol Biol. 265:131–158. 2004.PubMed/NCBI

14 

Hildebrand J, Rütze M, Walz N, Gallinat S, Wenck H, Deppert W, Grundhoff A and Knott A: A comprehensive analysis of microRNA expression during human keratinocyte differentiation in vitro and in vivo. J Invest Dermatol. 131:20–29. 2011. View Article : Google Scholar : PubMed/NCBI

15 

Cheng AM, Byrom MW, Shelton J and Ford LP: Antisense inhibition of human miRNAs and indications for an involvement of miRNA in cell growth and apoptosis. Nucleic Acids Res. 33:1290–1297. 2005. View Article : Google Scholar : PubMed/NCBI

16 

Yang X, Wang J, Guo SL, Fan KJ, Li J, Wang YL, Teng Y and Yang X: miR-21 promotes keratinocyte migration and re-epithelialization during wound healing. Int J Boil Sci. 7:685–690. 2011. View Article : Google Scholar

17 

Xu N, Brodin P, Wei T, Meisgen F, Eidsmo L, Nagy N, Kemeny L, Ståhle M, Sonkoly E and Pivarcsi A: MiR-125b, a microRNA downregulated in psoriasis, modulates keratinocyte proliferation by targeting FGFR2. J Invest Dermatol. 131:1521–1529. 2011. View Article : Google Scholar : PubMed/NCBI

18 

Liu K and Wang R: MicroRNA-mediated regulation in the mammalian circadian rhythm. J Theor Biol. 304:103–110. 2012. View Article : Google Scholar : PubMed/NCBI

19 

Cheng HY, Papp JW, Varlamova O, Dziema H, Russell B, Curfman JP, Nakazawa T, Shimizu K, Okamura H, Impey S and Obrietan K: microRNA modulation of circadian-clock period and entrainment. Neuron. 54:813–829. 2007. View Article : Google Scholar : PubMed/NCBI

20 

Shende VR, Neuendorff N and Earnest DJ: Role of miR-142-3p in the post-transcriptional regulation of the clock gene Bmal1 in the mouse SCN. PLoS One. 8:e653002013. View Article : Google Scholar : PubMed/NCBI

21 

Tan X, Zhang P, Zhou L, Yin B, Pan H and Peng X: Clock-controlled mir-142-3p can target its activator, Bmal1. BMC Mol Biol. 13:272012. View Article : Google Scholar : PubMed/NCBI

22 

Zhou BR, Xu Y, Permatasari F, Liu WL, Li W, Guo XF, Huang QH, Guo Z and Luo D: Characterization of the miRNA profile in UVB-irradiated normal human keratinocytes. Exp Dermatol. 21:317–319. 2012. View Article : Google Scholar : PubMed/NCBI

23 

Cha HJ, Kim OY, Lee GT, Lee KS, Lee JH, Park I, Lee SJ, Kim YR, Ahn KJ, An IS, et al: Identification of ultraviolet B radiation-induced microRNAs in normal human dermal papilla cells. Mol Med Rep. 10:1663–1670. 2014. View Article : Google Scholar : PubMed/NCBI

24 

Pothof J, Verkaik NS, van IJcken W, Wiemer EA, Ta VT, van der Horst GT, Jaspers NG, van Gent DC, Hoeijmakers JH and Persengiev SP: MicroRNA-mediated gene silencing modulates the UV-induced DNA-damage response. EMBO J. 28:2090–2099. 2009. View Article : Google Scholar : PubMed/NCBI

25 

Kim SR, Seo HS, Choi HS, Cho SG, Kim YK, Hong EH, Shin YC and Ko SG: Trichosanthes kirilowii ethanol extract and cucurbitacin D inhibit cell growth and induce apoptosis through inhibition of STAT3 activity in breast cancer cells. Evid Based Complement Alternat Med. 2013:9753502013. View Article : Google Scholar : PubMed/NCBI

26 

Shin JW, Son JY, Kang JK, Han SH, Cho CK and Son CG: Trichosanthes kirilowii tuber extract induces G2/M phase arrest via inhibition of tubulin polymerization in HepG2 cells. J Ethnopharmacol. 115:209–216. 2008. View Article : Google Scholar : PubMed/NCBI

27 

Livak KJ and Schmittgen TD: Anlysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001. View Article : Google Scholar : PubMed/NCBI

28 

Kang TH, Reardon JT, Kemp M and Sancar A: Circadian oscillation of nucleotide excision repair in mammalian brain. Proc Natl Acad Sci USA. 106:2864–2867. 2009. View Article : Google Scholar : PubMed/NCBI

29 

Kang TH, Lindsey-Boltz LA, Reardon JT and Sancar A: Circadian control of XPA and excision repair of cisplatin-DNA damage by cryptochrome and HERC2 ubiquitin ligase. Proc Natl Acad Sci USA. 107:4890–4895. 2010. View Article : Google Scholar : PubMed/NCBI

30 

Geyfman M, Kumar V, Liu Q, Ruiz R, Gordon W, Espitia F, Cam E, Millar SE, Smyth P, Ihler A, et al: Brain and muscle Arnt-like protein-1 (BMAL1) controls circadian cell proliferation and susceptibility to UVB-induced DNA damage in the epidermis. Proc Natl Acad Sci USA. 109:11758–11763. 2012. View Article : Google Scholar : PubMed/NCBI

31 

Xie QH, He XX, Chang Y, Sun SZ, Jiang X, Li PY and Lin JS: MiR-192 inhibits nucleotide excision repair by targeting ERCC3 and ERCC4 in HepG2.2.15 cells. Biochem Biophys Res Commun. 410:440–445. 2011. View Article : Google Scholar : PubMed/NCBI

32 

Ni L, Zhu X, Gong C, Luo Y, Wang L, Zhou W, Zhu S and Li Y: Trichosanthes kirilowii fruits inhibit non-small cell lung cancer cell growth through mitotic cell-cycle arrest. Am J Chin Med. 43:349–364. 2015. View Article : Google Scholar : PubMed/NCBI

33 

Bee L, Marini S, Pontarin G, Ferraro P, Costa R, Albrecht U and Celotti L: Nucleotide excision repair efficiency in quiescent human fibroblasts is modulated by circadian clock. Nucleic Acids Res. 43:2126–2137. 2015. View Article : Google Scholar : PubMed/NCBI

34 

Ramkissoon SH, Mainwaring LA, Ogasawara Y, Keyvanfar K, McCoy JP Jr, Sloand EM, Kajigaya S and Young NS: Hematopoietic-specific microRNA expression in human cells. Leuk Res. 30:643–647. 2006. View Article : Google Scholar : PubMed/NCBI

35 

Wang XS, Gong JN, Yu J, Wang F, Zhang XH, Yin XL, Tan ZQ, Luo ZM, Yang GH, Shen C and Zhang JW: MicroRNA-29a and microRNA-142-3p are regulators of myeloid differentiation and acute myeloid leukemia. Blood. 119:4992–5004. 2012. View Article : Google Scholar : PubMed/NCBI

36 

Lv M, Zhang X, Jia H, Li D, Zhang B, Zhang H, Hong M, Jiang T, Jiang Q, Lu J, et al: An oncogenic role of miR-142-3p in human T-cell acute lymphoblastic leukemia (T-ALL) by targeting glucocorticoid receptor-α and cAMP/PKA pathways. Leukemia. 26:769–777. 2012. View Article : Google Scholar : PubMed/NCBI

37 

Lei Z, Xu G, Wang L, Yang H, Liu X, Zhao J and Zhang HT: MiR-142-3p represses TGF-β-induced growth inhibition through repression of TGFβR1 in non-small cell lung cancer. FASEB J. 28:2696–2704. 2014. View Article : Google Scholar : PubMed/NCBI

38 

Joyce CE, Zhou X, Xia J, Ryan C, Thrash B, Menter A, Zhang W and Bowcock AM: Deep sequencing of small RNAs from human skin reveals major alterations in the psoriasis miRNAome. Hum Mol Genet. 20:4025–4040. 2011. View Article : Google Scholar : PubMed/NCBI

39 

Vennegaard MT, Bonefeld CM, Hagedorn PH, Bangsgaard N, Løvendorf MB, Odum N, Woetmann A, Geisler C and Skov L: Allergic contact dermatitis induces upregulation of identical microRNAs in humans and mice. Contact Dermatitis. 67:298–305. 2012. View Article : Google Scholar : PubMed/NCBI

40 

Makino K, Jinnin M, Kajihara I, Honda N, Sakai K, Masuguchi S, Fukushima S, Inoue Y and Ihn H: Circulating miR-142-3p levels in patients with systemic sclerosis. Clin Exp Dermatol. 37:34–39. 2012. View Article : Google Scholar : PubMed/NCBI

Related Articles

  • Abstract
  • View
  • Download
  • Twitter
Copy and paste a formatted citation
Spandidos Publications style
Joo JH, Hong IK, Kim NK and Choi E: Trichosanthes kirilowii extract enhances repair of UVB radiation‑induced DNA damage by regulating BMAL1 and miR‑142‑3p in human keratinocytes. Mol Med Rep 17: 877-883, 2018.
APA
Joo, J., Hong, I., Kim, N.K., & Choi, E. (2018). Trichosanthes kirilowii extract enhances repair of UVB radiation‑induced DNA damage by regulating BMAL1 and miR‑142‑3p in human keratinocytes. Molecular Medicine Reports, 17, 877-883. https://doi.org/10.3892/mmr.2017.7932
MLA
Joo, J., Hong, I., Kim, N. K., Choi, E."Trichosanthes kirilowii extract enhances repair of UVB radiation‑induced DNA damage by regulating BMAL1 and miR‑142‑3p in human keratinocytes". Molecular Medicine Reports 17.1 (2018): 877-883.
Chicago
Joo, J., Hong, I., Kim, N. K., Choi, E."Trichosanthes kirilowii extract enhances repair of UVB radiation‑induced DNA damage by regulating BMAL1 and miR‑142‑3p in human keratinocytes". Molecular Medicine Reports 17, no. 1 (2018): 877-883. https://doi.org/10.3892/mmr.2017.7932
Copy and paste a formatted citation
x
Spandidos Publications style
Joo JH, Hong IK, Kim NK and Choi E: Trichosanthes kirilowii extract enhances repair of UVB radiation‑induced DNA damage by regulating BMAL1 and miR‑142‑3p in human keratinocytes. Mol Med Rep 17: 877-883, 2018.
APA
Joo, J., Hong, I., Kim, N.K., & Choi, E. (2018). Trichosanthes kirilowii extract enhances repair of UVB radiation‑induced DNA damage by regulating BMAL1 and miR‑142‑3p in human keratinocytes. Molecular Medicine Reports, 17, 877-883. https://doi.org/10.3892/mmr.2017.7932
MLA
Joo, J., Hong, I., Kim, N. K., Choi, E."Trichosanthes kirilowii extract enhances repair of UVB radiation‑induced DNA damage by regulating BMAL1 and miR‑142‑3p in human keratinocytes". Molecular Medicine Reports 17.1 (2018): 877-883.
Chicago
Joo, J., Hong, I., Kim, N. K., Choi, E."Trichosanthes kirilowii extract enhances repair of UVB radiation‑induced DNA damage by regulating BMAL1 and miR‑142‑3p in human keratinocytes". Molecular Medicine Reports 17, no. 1 (2018): 877-883. https://doi.org/10.3892/mmr.2017.7932
Follow us
  • Twitter
  • LinkedIn
  • Facebook
About
  • Spandidos Publications
  • Careers
  • Cookie Policy
  • Privacy Policy
How can we help?
  • Help
  • Live Chat
  • Contact
  • Email to our Support Team